Skip to main content
. 2019 Feb 11;38(23):4590–4604. doi: 10.1038/s41388-019-0743-4

Fig. 3.

Fig. 3

PKNOX2 suppressed GC cell proliferation via induction of apoptosis and cell cycle arrest. a PKNOX2 overexpression in AGS and MKN45 cells was confirmed by RT-PCR and Western blot. b Subcellular localization of PKNOX2 in AGS and MKN45 cells. c PKNOX2 overexpression suppressed cell proliferation (both P < 0.0001) and (d) colony formation(AGS, P < 0.05;MKN45,P < 0.001). e Knockdown of PKNOX2 in GES1 cells was determined by RT-PCR and Western blot. f PKNOX2 silencing promoted GES1 cell growth (P < 0.01)and colony formation (P < 0.05). g PKNOX2 induced apoptosis in AGS and MKN45 cells. Apoptosis was determined by flow cytometry after Annexin V-PI/7-AAD staining (left)(AGS, P = 0.0179;MKN45, P = 0.0002). Apoptosis markers activated by PKNOX2 were determined by Western blot (right). h PKNOX2 increased cell population in G0/G1 phase(P < 0.0001), together with decreased S phase population (left)(P < 0.0001). PKNOX2 inhibited the expression of cyclin D1 and CDK4; but induced p21 and p27 expression (right). (*P < 0.05; **P < 0.001; ***P < 0.0001)